… or darunavir/ritonavir which increase the bleeding risk by inhibiting Cytochrome P450 3A4
(… prophylaxis in COVID-19 infected patients based on the patient's condition and risk factors. …

… The aim of this study was to assess whether COVID-19 infection increased the risk for VTE
… In conclusion, COVID-19 infection was not associated with an increased risk for VTE or PE in …

… of VTE in critically ill patients with COVID‐19, which is consistent with … risk group for
adverse outcomes and to raise clinicians’ awareness of VTE risk amongst critically ill COVID‐19 …

… Many patients with COVID-19 are at increased risk of venous thromboembolism (VTE).
Therefore, we recommend pharmacologic prophylaxis for patients with COVID-19 when …

… hemostatic system and thromboembolic disease. … COVID‐19 who are at risk of a coagulopathy
and thrombotic complications and (ii) patients with (new or a history of) thromboembolic …

… Similarly, limited data are currently available about the incidence of thromboembolic in Sub-…
, risk factor and outcome of cardiovascular thromboembolic complications among COVID-19 …

… COVID-19 is higher in these patients than in the general COVID-19 population and identifying
associated risk … , PV, and MF patients with COVID-19, recruited in specialized hematology …

… thromboembolism (VTE) among COVID-19 patients admitted to intensive care units. Electronic
databases were searched for studies reporting venous thromboembolic … [Increased risk of …

… bles related to risk factors associated with poor prognosis of both PE and COVID-19, which
… , our study indicates that COVID-19 disease does not add an increased risk of death or ICU …

… led to a wide chemoprophylaxis use for critically ill COVID-19 patients (3). … COVID-19
patients on chemoprophylaxis remain to carry a high risk of VTE compared with non-COVID-19 …